Zyvox, also known by its generic name linezolid, is an antibiotic used to treat serious infections caused by certain types of bacteria, particularly Gram-positive bacteria [1][2]. These infections can include pneumonia, skin and soft tissue infections, and infections associated with certain medical devices [1][2]. It is effective against bacteria that may be resistant to other antibiotics, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) [1][2].
How does Zyvox work?
Zyvox works by inhibiting bacterial protein synthesis [1][2]. It binds to the 50S ribosomal subunit of bacteria, preventing the formation of the initiation complex, which is necessary for bacterial growth and replication [1][2]. This mechanism of action distinguishes it from many other classes of antibiotics [1].
When did Zyvox first become available?
Zyvox was approved by the U.S. Food and Drug Administration (FDA) in 2000 [3].
What are the common side effects of Zyvox?
Common side effects reported with Zyvox include diarrhea, nausea, headache, and vomiting [1][2]. Some patients may also experience changes in taste, dizziness, or rash [1][2].
What are the risks associated with taking Zyvox?
Long-term use of Zyvox can be associated with serious side effects, including bone marrow suppression, leading to low platelet counts (thrombocytopenia), low white blood cell counts (neutropenia), and anemia [1][2]. There is also a risk of optic neuropathy (damage to the optic nerve) and peripheral neuropathy (nerve damage in the extremities), which can be irreversible [1][2]. Zyvox can also interact with certain medications, such as monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs), potentially leading to serotonin syndrome, a life-threatening condition [1][2]. Due to these risks, patients are typically monitored for blood counts and vision during treatment [1][2].
When does the patent for Zyvox expire?
Patent expiry dates for branded drugs can be complex, often involving multiple patents for the drug substance, formulation, and method of use [4]. Information regarding the specific patent expiry of Zyvox and potential generic entry can be found on specialized drug patent tracking websites [4]. For detailed information on Zyvox patent status and expiry, DrugPatentWatch.com is a resource [4].
Can generic versions of Zyvox be made?
Once the relevant patents and market exclusivity periods expire, generic versions of linezolid can be developed and approved by regulatory agencies like the FDA [3][4]. The availability of generic options typically leads to lower drug costs [4].
Who manufactures Zyvox?
Zyvox was originally developed and marketed by Pfizer [3]. Generic versions may be manufactured by various pharmaceutical companies after patent and exclusivity expirations [4].